Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
63.38B | 63.61B | 64.88B | 58.79B | 45.21B | 45.50B | Gross Profit |
6.21B | 6.76B | 6.39B | 4.37B | 4.33B | 4.60B | EBIT |
1.40B | 2.23B | 1.89B | 281.17M | 980.35M | 959.81M | EBITDA |
4.72B | 5.78B | 3.98B | 2.63B | 2.96B | 2.82B | Net Income Common Stockholders |
1.41B | 2.70B | 1.51B | 702.95M | 1.39B | 543.61M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
1.20B | 3.19B | 2.84B | 1.96B | 2.19B | 2.03B | Total Assets |
20.07B | 48.01B | 46.36B | 42.75B | 34.73B | 30.25B | Total Debt |
4.12B | 15.72B | 17.04B | 16.00B | 10.00B | 8.22B | Net Debt |
2.93B | 12.53B | 14.20B | 14.03B | 7.81B | 6.20B | Total Liabilities |
8.37B | 23.69B | 25.25B | 23.48B | 16.79B | 13.98B | Stockholders Equity |
11.69B | 24.29B | 21.09B | 19.26B | 17.92B | 16.26B |
Cash Flow | Free Cash Flow | ||||
0.00 | 1.34B | -63.61M | -6.29B | -1.40B | 817.95M | Operating Cash Flow |
0.00 | 3.22B | 4.91B | -4.75B | 153.83M | 2.73B | Investing Cash Flow |
0.00 | -1.96B | -4.98B | -1.36B | -1.49B | -1.92B | Financing Cash Flow |
0.00 | -1.63B | 890.99M | 5.70B | 1.46B | -627.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $20.45T | 17.92 | 14.40% | 0.53% | 9.56% | 26.52% | |
78 Outperform | $4.38T | 22.99 | 10.13% | 0.85% | -0.91% | 52.93% | |
78 Outperform | $13.71T | 34.70 | 13.62% | 0.57% | 9.09% | 9.30% | |
76 Outperform | ¥2.68T | 15.81 | 2.10% | 3.09% | 71.49% | ||
68 Neutral | $3.55T | 10.65 | 7.23% | 2.42% | 1.72% | -33.60% | |
66 Neutral | ¥5.88B | 3.23 | 5.95% | 6.64% | -20.25% | ||
59 Neutral | $9.97B | 10.09 | -6.54% | 3.08% | 7.41% | -11.60% |